Skip to main content

Main navigation

  • Rapid Reactions
  • Schizophrenia Foundations
  • Symptomatology
  • Patient Burden
  • Caregiver Perspectives
  • Psychopharmacology

Main navigation

  • Rapid Reactions
  • Schizophrenia Foundations
  • Symptomatology
  • Patient Burden
  • Caregiver Perspectives
  • Psychopharmacology

Can Peripherally Restricted Anticholinergics Like Trospium Reduce Risks?

September 17, 2025

HMP · Can Peripherally Restricted Anticholinergics Like Trospium Reduce Risks?

Greg Mattingly, MD examines safer alternatives and their limitations.

Related Content

Patient Concerns About Deprescribing: How to Address Them
Anticholinergic Misuse: Can These Medications Be Addictive?
Can Peripherally Restricted Anticholinergics Like Trospium Reduce Risks?
Why Should We Deprescribe Anticholinergics?
What’s the Role of Amantadine in Anticholinergic Deprescription?
Treatment Options and Managing Side Effects in Schizophrenia
Assessing Anticholinergic Burden
© 2026 HMP Global. All Rights Reserved.
Privacy Policy Terms of Use Cookie Policy